Medical Science Laboratory, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530003, People's Republic of China; Department of Genetic Metabolism, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530003, People's Republic of China.
Department of Genetic Metabolism, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530003, People's Republic of China.
Clin Chim Acta. 2019 Feb;489:103-108. doi: 10.1016/j.cca.2018.11.035. Epub 2018 Nov 30.
Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder. Although most patients present with isolated CH, some patients present with CH and extra-thyroidal congenital malformations (ECMs), for which less is known about the underlying genetics. The aim of this study was to investigate the genetic mechanisms in patients with CH and ECMs using chromosomal microarray (CMA) and whole exome sequencing (WES).
Peripheral venous blood samples were collected from 16 patients with CH and ECMs. Genomic DNA was extracted from peripheral blood leukocytes. CMA and WES were performed to detect copy number and single nucleotide variants.
CMA identified clinically significant copy number variants in 7 patients consistent with their phenotypes. For 6 of them, the genotype and phenotype suggested a syndromic diagnosis, and the remaining patient carried a pathogenic microdeletion and microduplication including GLIS3. WES analysis identified 9 different variants in 7 additional patients. The variants included 2 known mutations (c.1096C>T (p.Arg366Trp) in KCNQ1 and c.848C>A (p.Pro283Gln) in NKX2-5) and 7 novel variants: one nonsense mutation (c.4330C>T (p.Arg1444*) in ASXL3), one frameshift mutation (c.1253_1259delACTCTGG (p.Asp418fs) in TG), three missense variants (c.1472C>T (p.Thr491Ile) in TG, c.4604A>G (p.Asp1535Gly) in TG, and c.2139G>T (p.Glu713Asp) in DUOX2, and two splice site variants (c.944-1G>C and c.3693 + 1G>T) in DUOX2.
We report the first genetic study of CH patients with ECMs using CMA and WES. Overall, our detection rate for pathogenic and possibly pathogenic variants was 87.5% (14/16). We report 7 novel variants, expanding the mutational spectrum of TG, DUOX2, and ASXL3.
先天性甲状腺功能减退症(CH)是最常见的新生儿内分泌疾病。尽管大多数患者表现为单纯性 CH,但有些患者表现为 CH 和甲状腺外先天性畸形(ECMs),对其潜在遗传学了解较少。本研究旨在通过染色体微阵列(CMA)和全外显子组测序(WES)研究 CH 和 ECM 患者的遗传机制。
收集 16 例 CH 和 ECM 患者的外周静脉血样。从外周血白细胞中提取基因组 DNA。进行 CMA 和 WES 以检测拷贝数和单核苷酸变异。
CMA 在 7 例与表型一致的患者中发现具有临床意义的拷贝数变异。其中 6 例基因型和表型提示综合征诊断,其余患者携带 GLIS3 的致病性微缺失和微重复。WES 分析在另外 7 例患者中发现了 9 种不同的变异。这些变异包括 2 种已知突变(KCNQ1 中的 c.1096C>T(p.Arg366Trp)和 NKX2-5 中的 c.848C>A(p.Pro283Gln))和 7 种新变异:1 种无义突变(ASXL3 中的 c.4330C>T(p.Arg1444*)),1 种移码突变(TG 中的 c.1253_1259delACTCTGG(p.Asp418fs)),3 种错义变异(TG 中的 c.1472C>T(p.Thr491Ile),TG 中的 c.4604A>G(p.Asp1535Gly)和 DUOX2 中的 c.2139G>T(p.Glu713Asp)),2 种剪接位点变异(DUOX2 中的 c.944-1G>C 和 c.3693+1G>T)。
我们报告了使用 CMA 和 WES 对 CH 合并 ECM 患者进行的首次遗传学研究。总体而言,我们对致病性和可能致病性变异的检出率为 87.5%(14/16)。我们报告了 7 种新变异,扩大了 TG、DUOX2 和 ASXL3 的突变谱。